Your browser doesn't support javascript.
loading
Isolation and structural characterization of novel photolytic degradation impurities of Deflazacort using Q-TOF, 2D-NMR and FTIR.
Raju, Ch Krishnam; Pandey, Avadhesh Kumar; Ghosh, Kaushik; Pola, Arunima; Goud, Sanath Kumar; Jaywant, Mrunal A; Navalgund, Sameer G; Surendranath, Koduru V.
Afiliação
  • Raju CK; Analytical Research and Development, United States Pharmacopeial Convention-India (P) Ltd., Plot No. D6 & D8, IKP, Genome Valley, Shameerpet, Hyderabad,500078, India.
  • Pandey AK; Analytical Research and Development, United States Pharmacopeial Convention-India (P) Ltd., Plot No. D6 & D8, IKP, Genome Valley, Shameerpet, Hyderabad,500078, India.
  • Ghosh K; Analytical Research and Development, United States Pharmacopeial Convention-India (P) Ltd., Plot No. D6 & D8, IKP, Genome Valley, Shameerpet, Hyderabad,500078, India.
  • Pola A; Analytical Research and Development, United States Pharmacopeial Convention-India (P) Ltd., Plot No. D6 & D8, IKP, Genome Valley, Shameerpet, Hyderabad,500078, India.
  • Goud SK; Analytical Research and Development, United States Pharmacopeial Convention-India (P) Ltd., Plot No. D6 & D8, IKP, Genome Valley, Shameerpet, Hyderabad,500078, India. Electronic address: skg@usp.org.
  • Jaywant MA; Analytical Research and Development, United States Pharmacopeial Convention-India (P) Ltd., Plot No. D6 & D8, IKP, Genome Valley, Shameerpet, Hyderabad,500078, India.
  • Navalgund SG; Analytical Research and Development, United States Pharmacopeial Convention-India (P) Ltd., Plot No. D6 & D8, IKP, Genome Valley, Shameerpet, Hyderabad,500078, India.
  • Surendranath KV; Analytical Research and Development, United States Pharmacopeial Convention-India (P) Ltd., Plot No. D6 & D8, IKP, Genome Valley, Shameerpet, Hyderabad,500078, India.
J Pharm Biomed Anal ; 133: 82-89, 2017 Jan 30.
Article em En | MEDLINE | ID: mdl-27843100
ABSTRACT
Forced Degradation of Deflazacort drug substance in ultraviolet light condition resulted into a number of significant degradation products. Two of these degradation products were found to be unknown during the study and marked as DD-I and DD-II. Thus, the objective of this work is to investigate and identify these two novel degradation products of DFZ. The isolation method for these new degradation products were developed using a new reverse-phase high performance liquid chromatography (HPLC). DD-I and DD-II, eluting at 0.53 and 1.57 relative retention times with respect to Deflazacort (DFZ) peak respectively, were isolated from reaction mass using preparative HPLC and their structures were elucidated using high resolution MS, multidimensional NMR and FTIR spectroscopic techniques. To best of our knowledge, these two degradation products are novel impurities which are not discussed in any form of publication yet.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxazóis / Pregnenodionas Idioma: En Revista: J Pharm Biomed Anal Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxazóis / Pregnenodionas Idioma: En Revista: J Pharm Biomed Anal Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Índia
...